ATRA

Atara Biotherapeutics Stock Price

18.61
-0.24 (-1.27%)
Upgrade to Real-Time
Afterhours (Closed)
18.61
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
Atara Biotherapeutics Inc ATRA NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.24 -1.27% 18.61 20:00:00
Open Price Low Price High Price Close Price Prev Close
18.83 18.34 19.19 18.61 18.85
Bid Price Ask Price Spread News
18.08 18.70 0.62 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
7,818 930,574 $ 18.86 $ 17,546,600 1,069,325 4.52 - 28.20
Last Trade Time Type Quantity Stock Price Currency
19:53:16 1 $ 18.72 USD

Atara Biotherapeutics Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 1.54B 83.00M 72.61M $ - $ - -5.70 -4.10
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% -15.33k 2.60%

more financials information »

Atara Biotherapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ATRA Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week20.4020.8918.3419.67603,038-1.79-8.77%
1 Month21.71523.0918.3420.55808,999-3.11-14.3%
3 Months14.7528.2011.9720.53923,4343.8626.17%
6 Months14.0428.2011.3317.12832,5144.5732.55%
1 Year16.9428.204.5214.08954,4331.679.86%
3 Years28.1054.454.5222.74715,734-9.49-33.77%
5 Years20.9654.454.5221.80529,826-2.35-11.21%

Atara Biotherapeutics Description

Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing therapeutics for patients with serious life-threatening such as cancer, autoimmune and other viral diseases. The company achieves this through two groups of product candidates, such as allogenic or third-party derived antigen-specific T-cells and molecularly targeted biologics.


Your Recent History
NASDAQ
ATRA
Atara Biot..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.